Form 4: Sanara MedTech CEO Zachary Fleming Receives and Disposes of Shares
SEC Form 4
CEO Zachary Fleming reports the acquisition of 12,693 shares of restricted stock and the disposal of 48,854 shares of common stock on March 7, 2024.
Summary
- On March 7, 2024, Zachary B. Fleming, CEO of Sanara MedTech Inc., acquired 12,693 shares of common stock.
- These shares were granted as restricted stock under the company's 2014 Omnibus Long Term Incentive Plan.
- The restricted stock vests in three equal installments on March 7, 2025, 2026, and 2027.
- Fleming also disposed of 48,854 shares of common stock on the same day.
- Following these transactions, Fleming directly owns 48,854 shares of Sanara MedTech Inc.
Sentiment
Score: 5
Explanation: This is a routine regulatory filing, so the sentiment is neutral.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities and holdings in the company's stock.
Stakeholder Impact
- Shareholders are informed about the CEO's stock transactions, providing transparency.
Key Dates
| Date | Description |
|---|---|
| 03/07/2024 | Date of stock acquisition and disposal. |
| 03/07/2025 | First vesting date for restricted stock (one-third of shares). |
| 03/07/2026 | Second vesting date for restricted stock (one-third of shares). |
| 03/07/2027 | Third vesting date for restricted stock (one-third of shares). |
| 03/11/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.